ObsEva SA Cashflow Statement | Understand Stock

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018
NET LOSS BEFORE TAX FOR THE YEAR
Depreciation expense
Post-employment (benefit) / cost
Share-based compensation expense
Income tax paid
Other operating income
Finance expense, net
Other receivables
Prepaid expenses, deferred costs and other long-term assets
Other payables and current liabilities
Accrued expenses and other long-term liabilities
NET CASH FLOWS USED IN OPERATING ACTIVITIES
Cash used for rental deposits
Net proceeds from disposal of intangible assets
Payments for plant and equipment
Acquisition of a license
NET CASH FLOWS FROM (USED IN) INVESTING ACTIVITIES
Proceeds from issuance of shares
Proceeds from the exercise of warrants
Oxford loan repayment
Proceeds from issuance of convertible debt
Proceeds from issuance of warrants
Issuance costs related to convertible debt and warrant
Proceeds from exercise of stock-options
Proceeds from issuance of debt, net of issuance costs
Share issuance costs
Principal elements of lease payments
Interest paid
NET CASH FLOWS FROM FINANCING ACTIVITIES
Net (decrease) / increase in cash and cash equivalents
Effects of exchange rate changes on cash and cash equivalents
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense
Impairment loss on right-of-use asset
Change in fair value of warrant liability
Change in fair value of derivative liability
Loss on extinguishment of debt
Post-employment expense
Share-based compensation expense
Amortization of operating right-of-use assets
Foreign currency gain, net
Non-cash interest expense
Changes in operating assets and liabilities:
Accounts receivable
Prepaid expenses and other long-term assets
Operating lease liabilities
Accounts payable and other current liabilities
Accrued expenses
Net cash used in operating activities
CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from sale (purchases) of property, plant and equipment
Net cash provided by (used in) investing activities
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of shares in at-the-market offerings
Proceeds from issuance of convertible debt
Proceeds from issuance of warrants
Proceeds from the exercise of warrants
Prepayment of JGB convertible debt
Repayment of Oxford credit facility
Payments of issuance costs related to common shares
Payments of issuance costs related to convertible debt and warrant
Net cash (used in) provided by financing activities
Net (decrease) increase in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash - beginning of year
Effects of exchange rate changes on cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash - end of year
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for interest
Cash paid for taxes
SUPPLEMENTAL NON-CASH ACTIVITIES:
Issuance of common shares (in connection with conversion of convertible debt)

Comments